Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactate dehydrogenase A-like 6E, pseudogene (LDHAL6EP) is classified as a human pseudogene—a DNA sequence resembling a functional gene but incapable of producing a functional protein due to mutations or regulatory changes[3][6]. Pseudogenes were historically considered "junk DNA", but recent research shows that some can regulate their protein-coding relatives or participate in gene expression regulation by functioning as sources of noncoding RNA[7]. LDHAL6EP does not have an established protein product or direct biological function and has not been validated as a therapeutic target or implicated in disease via current scientific literature[1][3][5][6].
None known (as above, no drugs target this pseudogene, and it is not a protein-coding gene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactate dehydrogenase A-like 6E, pseudogene (LDHAL6EP).